The Nation - News from Jan. 19, 1988

Lypho-Med, a Chicago pharmaceutical concern, began recalling about 40,000 vials of the anti-fungous drug amphotericin B on Jan. 13 after the Food and Drug Administration voiced concern about fevers and chills seen one out of every 4,000 times the drug was administered, said Dr. John N. Kapoor, the company’s chairman and president. Amphoteracin is used to treat fungous diseases of the respiratory tract, swelling of the lymph glands and candidiasis, or chronic yeast infections of the skin, scalp, nails and other tissues. Candidiasis is frequently found in people with acquired immune deficiency syndrome.